Status:

WITHDRAWN

Myocardial Injury After Radical Nephrectomy

Lead Sponsor:

Sheffield Teaching Hospitals NHS Foundation Trust

Collaborating Sponsors:

University of Sheffield

Conditions:

Myocardial Injury

Eligibility:

All Genders

18+ years

Brief Summary

Kidney removal for cancer (nephrectomy) is a major operation. People can develop heart complications during or after surgery, especially if they are older or already have heart disease. One form of he...

Detailed Description

Patients undergoing nephrectomy have a greater risk of cardiac events requiring admission compared to the general population. For example, registry data report 21% of patients over 65 undergoing nephr...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Adult patients (aged 18 and above)
  • Undergoing a radical nephrectomy (either laparoscopic or robotic) for suspected renal cancer
  • Stage \<T3a
  • Can provide informed consent
  • Exclusion Criteria
  • Patients under 18
  • Undergoing partial nephrectomy
  • Undergoing radical nephrectomy not for suspected renal cancer
  • Unable to provide informed consent

Exclusion

    Key Trial Info

    Start Date :

    April 16 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2025

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT06515431

    Start Date

    April 16 2024

    End Date

    June 1 2025

    Last Update

    September 9 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield, United Kingdom, S10 2JF